Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
OTX015 | 202590-98-5
OTX015 – 美仑生物
OTX015 (Birabresib) (MK-8628; Birabresib) | CAS 202590-98-5 | AbMole ...
The BET inhibitor OTX015 reactivates latent HIV-1 through P-TEFb - PMC
OTX015 Epi-Drug Exerts Antitumor Effects in Ovarian Cancer Cells by ...
OTX015 triggers apoptosis in EPN cell lines. Western blot analysis of ...
BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute ...
BET-PROTAC ARV-771 is more potent than BETi OTX015 in reducing the in ...
The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in ...
The BET Inhibitor OTX015 Exhibits In Vitro and In Vivo Antitumor ...
(A) OTX015 induces cell cycle changes in OTX015-sensitive NSCLC cell ...
BET Bromodomain Inhibitors OTX015 Promote Killing of Hepatocellular ...
OTX015 (MK‐8628), a novel BET inhibitor, displays in vitro and in vivo ...
OTX015 levels in plasma and tumor tissue of SUDHL2-tumor bearing mice ...
OTX015 induces HIV-1 expression in vitro in latent HIV-1 cell culture ...
OTX015 exposure radiosensitizes OC cells by inducing apoptosis and ...
Bromodomain inhibitor OTX015 in patients with lymphoma or multiple ...
Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose ...
Effect of flow rate on the separation of OTX015 enantiomers | Download ...
(PDF) BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in ...
Antitumor activity of OTX015 in combination with everolimus in vitro ...
Characterization of OTX015 antiproliferative activity in three TNBC ...
OTX015 does not induce expression of T cell activation markers on ...
OTX015 and WT-161 synergistically inhibit the proliferation of OS ...
(PDF) OTX015 Epi-Drug Exerts Antitumor Effects in Ovarian Cancer Cells ...
OTX015 treatment reduces BRD4 binding to chromatin and leads to ...
Effect of OTX015 on the cell cycle and apoptosis in AML and ALL cell ...
OTX015 induces latent HIV-1 expression in ex vivo primary CD4 + T cells ...
OTX015 alone and in combination induces G1 arrest in NB cells. A ...
OTX015 displays antiproliferative activity in ALK-positive ALCL in ...
The BET inhibitor OTX015 reactivates latent HIV-1 through P-TEFb ...
OTX015 modulates MYC and BRD expression. A. MYC mRNA and protein levels ...
Bromodomain inhibitor OTX015 (MK-8628) combined with targeted agents ...
Effect of OTX015 on the expression of cancer stem cell markers in TNBC ...
OTX015 suppresses growth of T-47D cells expressing ESR1 Y537S mutation ...
In vivo effects of single agents OTX015 (50 mg/kg/BID and 100 ...
The BET Bromodomain Inhibitor OTX015 Synergizes with Targeted Agents in ...
The synergistic anticancer effect of the bromodomain inhibitor OTX015 ...
The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity ...
The MDM2 inhibitor CGM097 combined with the BET inhibitor OTX015 ...
Effect of modifier on the separation of OTX015 enantiomers | Download ...
EC50 values and ray design combination assays for CGM097 and OTX015 ...
Figure. OTX015: Turning off bromodomains target genes transcription ...
Structural representation of (±)-OTX015 and (±)-JQ1 | Download ...
Birabresib (OTX015) | BET Inhibitor | CAS 202590-98-5 | Selleck Chemicals
OTX015/WT-161 synergistically inhibits the metastasis and stem ...
OTX015-mediated effects in leukemia cell models. After a 48-h treatment ...
Targeted Therapy of TERT-Rearranged Neuroblastoma with BET Bromodomain ...
Birabresib (OTX015) | 比拉瑞塞 | 购买BET 抑制剂 - Selleck
Effect of OTX015/WT-161 on apoptosis and the cell cycle of OS cells in ...
美国APExBIO中文官网 - OTX-015|BRD inhibitor|CAS# 202590-98-5
Birabresib (OTX015) | Epigenetic Reader Domain inhibitor | CAS 202590 ...
Birabresib (OTX015) | 购买Epigenetic Reader Domain 抑制剂 - Selleck
HPLC chromatogram of the (−)-OTX015 bulk samples (1.0 mg mL−1) spiked ...
Bromodomain抑制剂OTX015在多发性骨髓瘤中的强活性。,Molecular Pharmaceutics - X-MOL
Resistance of β-catenin overexpression to the tumour-suppressing ...
Calibration curve of (+)-OTX015 | Download Scientific Diagram
OTX-015 - Potent BRD Inhibitor for Epigenetic Research | APExBIO
The BET inhibitor, OTX015, displays antitumoral activity against ...
Gene expression profiling in OTX015-treated TNBC cell models. (A) GEP ...
Birabresib (OTX015) | エピジェネティックリーダードメイン 阻害剤
Co-treatment with ziftomenib and BCL2 inhibitor, venetoclax, or BET ...
Therapeutic efficacy of the bromodomain inhibitor OTX015/MK-8628 in ALK ...
Epigenetics – 第 3 页 – 美仑生物
Ex vivo and in vivo treatment of patient-derived NPM1c bone marrow ...
00021-1/asset/8e447668-7781-4e12-b476-b54a6fdce72d/main.assets/gr2_lrg.jpg)
00021-1/asset/a5b8c908-16fa-4cfe-b97d-3b726821433a/main.assets/gr1_lrg.jpg)
00247-1/asset/e1baff69-5b5a-4f27-b790-71f244e1f4b9/main.assets/gr1_lrg.jpg)
00021-1/asset/3d450b2f-20cf-43e1-a9dc-86f535724576/main.assets/gr3_lrg.jpg)
00247-1/asset/92af9f60-07ca-4c06-a28c-eb0a97dfe09b/main.assets/gr2_lrg.jpg)
